ENGINEERING LIFE
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Dec 2024)
What this means for you
This application is over — abandoned 02 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90893595
- Mark type
- Stylized text
- Filed
- 20 Aug 2021
- Published for opposition
- 22 Feb 2022
- Abandoned
- 02 Dec 2024
- Attorney of record
- Chidera N. Dawodu
Goods and services
- Class 001 — Chemicals: Biological tissue cultures, namely, bone marrow, stem cells, and blood, all for use in scientific and medical research; cells for scientific, laboratory and medical research
- Class 005 — Pharmaceuticals: Biological tissues, namely, bone marrow, stem cells, and blood, all for use in medical therapy; cells for medical therapy use; cell therapies for use in organ and limb transplantation in the nature of cells for medical use; medicines for immune tolerance induction
- Class 039 — Transportation and storage services: Distribution services, namely, delivery of bone marrow and isolated cells to hospitals, biomedical research centers, and biotechnology companies; biomedical services, namely, storage of human cells, blood, and tissue for medical use
- Class 040 — Treatment of materials: Bone marrow processing for preparation for medical transport
- Class 042 — Scientific and technological services: Biological, technical and scientific research in the fields of oncology, immunology and organ and limb transplantation, wound healing, and radiation treatment
- Class 044 — Medical, beauty and agricultural services: Medical testing of bone marrow for diagnostic or treatment purposes; tissue bank services in the nature of collection and preservation of human bone marrow; cultured cell bank services for medical transplantation; Human blood, cultured cell, and tissue bank services; collection and preservation of human blood, cells and tissue; providing medical information in the fields of collection and preservation of human blood, cells and tissue via a website, newsletters and blog articles; autologous transplant services; stem cell therapy services in the nature of cell therapies deriving from hematopoietic stem cells; regenerative medicine services, namely, platelet-rich plasma and stem cell therapy services
Owner
- Ossium Health, Inc., San Francisco, CA, US
- Ossium Health, Inc., San Francisco, CA, US
Prosecution history
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Apr 2024 — SOU EXTENSION 4 GRANTED
- 19 Apr 2024 — SOU EXTENSION 4 FILED
- 19 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2023 — SOU EXTENSION 3 GRANTED
- 19 Oct 2023 — SOU EXTENSION 3 FILED
- 19 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Apr 2023 — SOU EXTENSION 2 GRANTED
- 19 Apr 2023 — SOU EXTENSION 2 FILED